EyePoint (EYPT) Change in Receivables (2011 - 2026)
EyePoint (EYPT) posted Change in Receivables of $5.0 million for Q1 2026, down 54.05% sequentially from $10.8 million in Q4 2025, and up 244.52% YoY from $1.4 million in Q1 2025.
EyePoint (EYPT) Change in Receivables (2011 - 2026) Analysis & Trends
EyePoint has reported Change in Receivables for 16 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Change in Receivables rose 244.52% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 355.9% YoY) and the FY2025 annual result came in at $10.7 million, up 4271.72% from the prior year.
- Change in Receivables fell to $5.0 million in Q1 2026 per EYPT's latest filing, from $10.8 million in the prior quarter.
- Over five years, Change in Receivables peaked at $10.8 million in Q4 2025 and troughed at -$10.7 million in Q3 2023.
- A 5-year average of $240882.4 and a median of $269000.0 in 2023 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables slumped 2820.65% in 2023, then jumped 678.69% in 2025.
- Over 5 years, Change in Receivables stood at -$6.3 million in 2022, then soared by 104.28% to $269000.0 in 2023, then slumped by 792.57% to -$1.9 million in 2024, then surged by 678.69% to $10.8 million in 2025, then tumbled by 54.05% to $5.0 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $5.0 million, $10.8 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | -19.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.25 Mn |
| Jun 30, 2026 | -19.25 Mn |
| Mar 31, 2026 | 4.95 Mn |
| Mar 31, 2026 | 4.95 Mn |
| Dec 31, 2025 | 10.78 Mn |
| Dec 31, 2025 | 10.78 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | -3.43 Mn |
| Mar 31, 2025 | -3.43 Mn |
| Dec 31, 2024 | -1.86 Mn |
| Dec 31, 2024 | -1.86 Mn |
| Sep 30, 2024 | 939,000.00 |
| Sep 30, 2024 | 939,000.00 |
| Jun 30, 2024 | -3.09 Mn |
| Jun 30, 2024 | -3.09 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Mar 31, 2024 | 4.26 Mn |